Oximus Remedies Private Limited
Pharmaceutical company that manufactures, formulates, and markets drugs, essential oils, and herbal extracts.
2017 | Delhi (India) | Active
Oximus Remedies Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 7 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 5.00 M
- Revenue Growth 87.41%
- Profit Growth 6995.27%
- Ebitda -227.29%
- Net Worth 8.08%
- Total Assets 60.08%
About Oximus Remedies
Oximus Remedies Private Limited (ORPL) is a Private Limited Indian Non-Government Company incorporated in India on 04 September 2017 (Seven years and five months 26 days old ). Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company has closed loans amounting to ₹5.00 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Anil Bansal and Sunita Bansal serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24303DL2017PTC323156
- Company No.
323156
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Sep 2017
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Pharma
What products or services does Oximus Remedies Private Limited offer?
Oximus Remedies Private Limited offers a wide range of products and services, including Common Disease Medicines, Pharmaceutical Medicine.
Who are the key members and board of directors at Oximus Remedies?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anil Bansal  | Director | 04-Sep-2017 | Current |
| Sunita Bansal | Director | 04-Sep-2017 | Current |
Financial Performance of Oximus Remedies.
Oximus Remedies Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 87.41% increase. The company also saw a substantial improvement in profitability, with a 6995.27% increase in profit. The company's net worth moved up by a moderate rise of 8.08%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Oximus Remedies?
In 2018, Oximus Remedies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
Open Charges
₹0
Satisfied Charges
₹5.00 M
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 0.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 05 May 2022 | Hdfc Bank Limited | ₹5.00 M | Satisfied |
How Many Employees Work at Oximus Remedies?
Unlock and access historical data on people associated with Oximus Remedies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Oximus Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Oximus Remedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Oximus Remedies
Recent activity within the organization
- Annual General Meeting
Oximus Remedies Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
30 Sep 2024
- Balance Sheet
Oximus Remedies Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
31 Mar 2024
- Charges
A charge registered on 05 May 2022 via Charge ID 100571250 with Hdfc Bank Limited was fully satisfied on 09 Feb 2024.
09 Feb 2024
- Charges
A charge with Hdfc Bank Limited amounted to Rs. 5.00 M with Charge ID 100571250 was registered on 05 May 2022.
05 May 2022
- Director Appointment
Anil Bansal was appointed as a Director was appointed as a Director on 04 Sep 2017 & has been associated with this company since 7 years 5 months .
04 Sep 2017
- Director Appointment
Sunita Bansal was appointed as a Director was appointed as a Director on 04 Sep 2017 & has been associated with this company since 7 years 5 months .
04 Sep 2017
Frequently asked questions
What is the Incorporation or founding date of Oximus Remedies Private Limited?
Oximus Remedies Private Limited was incorporated on 04 Sep 2017.
What is authorized share capital and paid-up capital of Oximus Remedies Private Limited?
The authorized share capital of Oximus Remedies Private Limited is ₹ 1.00 M and paid-up capital is ₹ 1.00 M.
Who are the current board members & directors of Oximus Remedies Private Limited?
Currently 2 directors are associated with Oximus Remedies Private Limited.
- Anil Bansal
- Sunita Bansal
What is the registered address of Oximus Remedies Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Oximus Remedies Private Limited is Khasra No. 68/1 Shop 18 Bhagwati Market Main Road, Bhorgarh India, Delhi, 110040.
What is the corporate identification number (CIN) and company number of Oximus Remedies Private Limited?
The corporate identification number (CIN) of Oximus Remedies Private Limited is U24303DL2017PTC323156 and the company number is 323156 as per Ministry of Corporate Affairs (MCA).
What has been the recent revenue trend for Oximus Remedies Private Limited?
According to the financial reports for the fiscal year 2022, the revenue trend for Oximus Remedies Private Limited has risen by 87.41%.
What change has been observed in the net worth of Oximus Remedies Private Limited, and by what percentage?
The financial reports for the fiscal year 2022 indicates that The net worth of Oximus Remedies Private Limited has experienced an upsurge of 8.08%.
When was the last Balance Sheet of Oximus Remedies Private Limited filed with the ROC?
The most recent Balance Sheet for Oximus Remedies Private Limited was filed with the ROC on 31 Mar 2024.